https://www.zonebourse.com/cours/action/JOHNSON-JOHNSON-4832/actualite/J-J-avis-favorable-de-l-UE-pour-un-anti-leucemique-40808921/?utm_source=telegram&utm_medium=social&utm_campaign=share